Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Clinical trial NCT04809623 · TERMINATED

Trial details

NCT number: NCT04809623
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Lupus Erythematosus

Start date: 2021-09-01
Primary completion: 2022-10-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.